share_log

LifeWallet Reveals $3.1M Settlement In Latest Pharmaceutical Antitrust Case

Benzinga ·  Aug 19 02:36
  • Company also announces a drive to secure agreements with health plans, property & casualty insurers, attorneys, and healthcare providers, including hospital systems
  • This subscription licensing is expected to generate revenue through fees charged on savings from unnecessary Medicare secondary payments
  • This is all part of LifeWallet's clearinghouse system, through its exclusive healthcare partnership with Palantir Technologies, Inc.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment